Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Ramucirumab
×
Genitourinary
×
Clear all
Filters
3
NCT02426125
2023-08-21
RANGE
Eli Lilly and Company
Phase 3
Completed
530 enrolled
22 charts